Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
GLP-1 Receptor Interaction Researchers analyse Retatrutide for its interaction with GLP-1 (Glucagon-Like Peptide-1) receptors in controlled laboratory studies
This has led to ethical concerns, as the increased demand helped create a shortage of these drugs around the world in recent months
Las preferencias del paciente importan
Retatrutide targets three hormones
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, distinguishing it from approved medicines such as semaglutide and tirzepatide
Reproducibility, audited
US$ 21.41
US$ 29.82
US$ 29.33
US$ 25.06
US$ 28.10
US$ 20.69
